+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Octapharma AG - logo

Octapharma is a privately-owned global human proteins manufacturer headquartered in Lachen, Switzerland. It develops human proteins that are derived from human plasma and human cell-lines. The company provides biopharmaceutical products and therapies for haematology, intensive care & emergency medicine, and immunotherapy. Octapharma owns and operates six state of the art plants, employing over 6,000 workers globally. It was founded in 1983 by Wolfgang Marguerre.

Immunoglobulins Market Report 2025 - Product Thumbnail Image

Immunoglobulins Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Intravenous Immunoglobulin Market Report 2025 - Product Thumbnail Image

Intravenous Immunoglobulin Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
From
Guillain-Barre Syndrome Market - Global Forecast 2025-2032 - Product Thumbnail Image

Guillain-Barre Syndrome Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 193 Pages
  • Global
From
From
From
From
From
Global Blood Plasma Products Market (2018-2023) - Product Thumbnail Image

Global Blood Plasma Products Market (2018-2023)

  • Report
  • June 2019
  • 71 Pages
  • Global
Complement C1 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Complement C1 Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator